Headquarters
Singapore

MiRXES

MiRXES is a biotechnology company that provides molecular blood tests for the detection of various cancers, including gastric and lung cancer, and offers next-generation sequencing services for cancer treatment. It gives solutions for research genomics and biobanking, utilizing microRNA detection technology.

Visit the MiRXES website

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2026 World Economic Forum